ClinConnect ClinConnect Logo
Search / Trial NCT01090401

Linox Smart S DX PME/Master Study

Launched by BIOTRONIK SE & CO. KG · Mar 18, 2010

Trial Information

Current as of May 01, 2025

Completed

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients with standard ICD indication
  • Be available for follow-up visits on a regular basis at an approved investigational center
  • Exclusion Criteria:
  • Patients with standard ICD contra-indication
  • Patients with permanent atrial fibrillation
  • Have a life expectancy of less than six months
  • Are expecting to receive cardiac surgery within 6 months after enrollment
  • Age \< 18 years
  • Not enrolled in another cardiac clinical investigation

About Biotronik Se & Co. Kg

Biotronik SE & Co. KG is a global leader in the development of innovative medical technology, specializing in cardiovascular and endovascular solutions. With a strong commitment to enhancing patient outcomes, the company focuses on advanced therapies and devices, including implantable cardioverter-defibrillators, cardiac resynchronization therapy, and vascular interventions. Biotronik's rigorous research and development initiatives, coupled with its dedication to clinical excellence, position the company at the forefront of medical advancement, striving to improve quality of life for patients worldwide. Through strategic partnerships and a robust clinical trial portfolio, Biotronik continues to drive innovation and set new standards in healthcare.

Locations

Berlin, , Germany

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials